A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema

Clinical trial NCT05466747 · WITHDRAWN

Trial details

NCT number: NCT05466747
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)Alpha1-Antitrypsin Deficiency

Start date: 2024-01-01
Primary completion: 2027-04-26
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.